Cover Image
Market Research Report
Product code 
1072551

North America Transcriptomics Market Size, Share & Industry Trends Analysis Report By Technology (q PCR, Microarrays, and Sequencing Technology), By Application, By Component, By Country and Growth Forecast, 2021 - 2027

Published: | KBV Research | 90 Pages | Delivery time: 1-2 business days

Price

Back to Top
North America Transcriptomics Market Size, Share & Industry Trends Analysis Report By Technology (q PCR, Microarrays, and Sequencing Technology), By Application, By Component, By Country and Growth Forecast, 2021 - 2027
Published: March 31, 2022
KBV Research
Content info: 90 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

The North America Transcriptomics Market would witness market growth of 6.9% CAGR during the forecast period (2021-2027).

Technological improvements and a surge in research grants from various institutes are two reasons that are expected to propel the transcriptomics market during the forecasting period. Moreover, the potential for RNAs to be used as diagnostic biomarkers and predictors of treatment response is the key industry trend. Previously, transcriptomics applications were limited to basic gene expression profiling and other research applications like determining the amount of RNA in a biological sample and studying gene expression. Other more prominent transcriptome uses are reported only after the simplification of transcriptomics technologies, reduction in technological costs, and increased awareness of transcriptomics technologies among both scientific intelligentsia and the general public.

The rapid development of structure-based medication designs, increased focus on transcriptomics research, and significant investment in biopharmaceutical research and development are the key trends of the regional market. In addition, rising funding in pharmaceutical research and development by the governments of different regional countries would create a conducive environment for the regional market players. North America, particularly the United States, is home to the majority of key players of transcriptomic systems, platforms, equipment, and technologies. Rebus Biosystems, for example, debuted its spatial transcriptomics analysis platform "spatial omics" system in 2021, which is aimed to allow researchers to examine the output of individual cells across tissue samples in more detail.

North American countries have experienced and continue to incur a major economic and healthcare burden as a result of COVID-19's high transmission rate and lack of therapy. The sale of reagents and consumables used in transcriptomics analysis has decreased as a result of the closure of research and academic institutes.

The US market dominated the North America Transcriptomics Market by Country 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $2,674 million by 2027. The Canada market is poised to grow at a CAGR of 9.4% during (2021 - 2027). Additionally, The Mexico market would exhibit a CAGR of 8.4% during (2021 - 2027).

Based on Technology, the market is segmented into q PCR, Microarrays, and Sequencing Technology. Based on Application, the market is segmented into Drug Discovery, Diagnostics & Disease Profiling, and Others. Based on Component, the market is segmented into Consumables, Instruments, Software, and Services. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Fluidigm Corporation, Promega Corporation, General Electric (GE) Co., Merck & Co., Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., and Qiagen N.V.

Scope of the Study

Market Segments covered in the Report:

By Technology

  • q PCR
  • Microarrays
  • Sequencing Technology

By Application

  • Drug Discovery
  • Diagnostics & Disease Profiling
  • Others

By Component

  • Consumables
  • Instruments
  • Software
  • Services

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled

  • Fluidigm Corporation
  • Promega Corporation
  • General Electric (GE) Co.
  • Merck & Co., Inc.
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Qiagen N.V.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 North America Transcriptomics Market, by Technology
    • 1.4.2 North America Transcriptomics Market, by Application
    • 1.4.3 North America Transcriptomics Market, by Component
    • 1.4.4 North America Transcriptomics Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
    • 3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2019, Jan - 2021, Apr) Leading Players
    • 3.3.3 Key Strategic Move: (Product Launches ad Product Expansions: 2018, Mar - 2021, Nov) Leading Players

Chapter 4. North America Transcriptomics Market by Technology

  • 4.1 North America q PCR Market by Country
  • 4.2 North America Microarrays Market by Country
  • 4.3 North America Sequencing Technology Market by Country

Chapter 5. North America Transcriptomics Market by Application

  • 5.1 North America Drug Discovery Market by Country
  • 5.2 North America Diagnostics & Disease Profiling Market by Country
  • 5.3 North America Others Market by Country

Chapter 6. North America Transcriptomics Market by Component

  • 6.1 North America Consumables Market by Country
  • 6.2 North America Instruments Market by Country
  • 6.3 North America Software Market by Country
  • 6.4 North America Services Market by Country

Chapter 7. North America Transcriptomics Market by Country

  • 7.1 US Transcriptomics Market
    • 7.1.1 US Transcriptomics Market by Technology
    • 7.1.2 US Transcriptomics Market by Application
    • 7.1.3 US Transcriptomics Market by Component
  • 7.2 Canada Transcriptomics Market
    • 7.2.1 Canada Transcriptomics Market by Technology
    • 7.2.2 Canada Transcriptomics Market by Application
    • 7.2.3 Canada Transcriptomics Market by Component
  • 7.3 Mexico Transcriptomics Market
    • 7.3.1 Mexico Transcriptomics Market by Technology
    • 7.3.2 Mexico Transcriptomics Market by Application
    • 7.3.3 Mexico Transcriptomics Market by Component
  • 7.4 Rest of North America Transcriptomics Market
    • 7.4.1 Rest of North America Transcriptomics Market by Technology
    • 7.4.2 Rest of North America Transcriptomics Market by Application
    • 7.4.3 Rest of North America Transcriptomics Market by Component

Chapter 8. Company Profiles

  • 8.1 Fluidigm Corporation
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Regional Analysis
    • 8.1.4 Research & Development Expenses
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Product Launches and Product Expansions:
  • 8.2 Promega Corporation
    • 8.2.1 Company Overview
  • 8.3 General Electric (GE) Co. (GE Healthcare)
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expense
  • 8.4 Merck & Co., Inc.
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expenses
  • 8.5 Thermo Fisher Scientific, Inc.
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expense
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Acquisition and Mergers:
    • 8.5.6 SWOT Analysis
  • 8.6 Illumina, Inc.
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Regional Analysis
    • 8.6.4 Research & Development Expense
    • 8.6.5 Recent strategies and developments:
      • 8.6.5.1 Partnerships, Collaborations, and Agreements:
  • 8.7 Bio-Rad laboratories, Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
    • 8.7.4 Research & Development Expenses
    • 8.7.5 Recent strategies and developments:
      • 8.7.5.1 Partnerships, Collaborations, and Agreements:
      • 8.7.5.2 Product Launches and Product Expansions:
      • 8.7.5.3 Acquisition and Mergers:
  • 8.8 Agilent Technologies, Inc.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental and Regional Analysis
    • 8.8.4 Research & Development Expense
    • 8.8.5 Recent strategies and developments:
      • 8.8.5.1 Acquisition and Mergers:
  • 8.9 F. Hoffmann-La Roche Ltd.
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental and Regional Analysis
    • 8.9.4 Research & Development Expense
  • 8.10. Qiagen N.V.
    • 8.10.1 Company Overview
    • 8.10.2 Financial Analysis
    • 8.10.3 Regional Analysis
    • 8.10.4 Research & Development Expense
    • 8.10.5 Recent strategies and developments:
      • 8.10.5.1 Partnerships, Collaborations, and Agreements:
      • 8.10.5.2 Product Launches and Product Expansions:
      • 8.10.5.3 Acquisition and Mergers:

LIST OF TABLES

  • TABLE 1 North America Transcriptomics Market, 2017 - 2020, USD Million
  • TABLE 2 North America Transcriptomics Market, 2021 - 2027, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements - Transcriptomics Market
  • TABLE 4 Product Launches And Product Expansions - Transcriptomics Market
  • TABLE 5 Acquisition and Mergers- Transcriptomics Market
  • TABLE 6 North America Transcriptomics Market by Technology, 2017 - 2020, USD Million
  • TABLE 7 North America Transcriptomics Market by Technology, 2021 - 2027, USD Million
  • TABLE 8 North America q PCR Market by Country, 2017 - 2020, USD Million
  • TABLE 9 North America q PCR Market by Country, 2021 - 2027, USD Million
  • TABLE 10 North America Microarrays Market by Country, 2017 - 2020, USD Million
  • TABLE 11 North America Microarrays Market by Country, 2021 - 2027, USD Million
  • TABLE 12 North America Sequencing Technology Market by Country, 2017 - 2020, USD Million
  • TABLE 13 North America Sequencing Technology Market by Country, 2021 - 2027, USD Million
  • TABLE 14 North America Transcriptomics Market by Application, 2017 - 2020, USD Million
  • TABLE 15 North America Transcriptomics Market by Application, 2021 - 2027, USD Million
  • TABLE 16 North America Drug Discovery Market by Country, 2017 - 2020, USD Million
  • TABLE 17 North America Drug Discovery Market by Country, 2021 - 2027, USD Million
  • TABLE 18 North America Diagnostics & Disease Profiling Market by Country, 2017 - 2020, USD Million
  • TABLE 19 North America Diagnostics & Disease Profiling Market by Country, 2021 - 2027, USD Million
  • TABLE 20 North America Others Market by Country, 2017 - 2020, USD Million
  • TABLE 21 North America Others Market by Country, 2021 - 2027, USD Million
  • TABLE 22 North America Transcriptomics Market by Component, 2017 - 2020, USD Million
  • TABLE 23 North America Transcriptomics Market by Component, 2021 - 2027, USD Million
  • TABLE 24 North America CONSUMABLES MARKET by Country, 2017 - 2020, USD Million
  • TABLE 25 North America CONSUMABLES MARKET by Country, 2021 - 2027, USD Million
  • TABLE 26 North America INSTRUMENTS MARKET by Country, 2017 - 2020, USD Million
  • TABLE 27 North America INSTRUMENTS MARKET by Country, 2021 - 2027, USD Million
  • TABLE 28 North America SOFTWARE MARKET by Country, 2017 - 2020, USD Million
  • TABLE 29 North America Software Market by Country, 2021 - 2027, USD Million
  • TABLE 30 North America Services Market by Country, 2017 - 2020, USD Million
  • TABLE 31 North America Services Market by Country, 2021 - 2027, USD Million
  • TABLE 32 North America Transcriptomics Market by Country, 2017 - 2020, USD Million
  • TABLE 33 North America Transcriptomics Market by Country, 2021 - 2027, USD Million
  • TABLE 34 US Transcriptomics Market, 2017 - 2020, USD Million
  • TABLE 35 US Transcriptomics Market, 2021 - 2027, USD Million
  • TABLE 36 US Transcriptomics Market by Technology, 2017 - 2020, USD Million
  • TABLE 37 US Transcriptomics Market by Technology, 2021 - 2027, USD Million
  • TABLE 38 US Transcriptomics Market by Application, 2017 - 2020, USD Million
  • TABLE 39 US Transcriptomics Market by Application, 2021 - 2027, USD Million
  • TABLE 40 US Transcriptomics Market by Component, 2017 - 2020, USD Million
  • TABLE 41 US Transcriptomics Market by Component, 2021 - 2027, USD Million
  • TABLE 42 Canada Transcriptomics Market, 2017 - 2020, USD Million
  • TABLE 43 Canada Transcriptomics Market, 2021 - 2027, USD Million
  • TABLE 44 Canada Transcriptomics Market by Technology, 2017 - 2020, USD Million
  • TABLE 45 Canada Transcriptomics Market by Technology, 2021 - 2027, USD Million
  • TABLE 46 Canada Transcriptomics Market by Application, 2017 - 2020, USD Million
  • TABLE 47 Canada Transcriptomics Market by Application, 2021 - 2027, USD Million
  • TABLE 48 Canada Transcriptomics Market by Component, 2017 - 2020, USD Million
  • TABLE 49 Canada Transcriptomics Market by Component, 2021 - 2027, USD Million
  • TABLE 50 Mexico Transcriptomics Market, 2017 - 2020, USD Million
  • TABLE 51 Mexico Transcriptomics Market, 2021 - 2027, USD Million
  • TABLE 52 Mexico Transcriptomics Market by Technology, 2017 - 2020, USD Million
  • TABLE 53 Mexico Transcriptomics Market by Technology, 2021 - 2027, USD Million
  • TABLE 54 Mexico Transcriptomics Market by Application, 2017 - 2020, USD Million
  • TABLE 55 Mexico Transcriptomics Market by Application, 2021 - 2027, USD Million
  • TABLE 56 Mexico Transcriptomics Market by Component, 2017 - 2020, USD Million
  • TABLE 57 Mexico Transcriptomics Market by Component, 2021 - 2027, USD Million
  • TABLE 58 Rest of North America Transcriptomics Market, 2017 - 2020, USD Million
  • TABLE 59 Rest of North America Transcriptomics Market, 2021 - 2027, USD Million
  • TABLE 60 Rest of North America Transcriptomics Market by Technology, 2017 - 2020, USD Million
  • TABLE 61 Rest of North America Transcriptomics Market by Technology, 2021 - 2027, USD Million
  • TABLE 62 Rest of North America Transcriptomics Market by Application, 2017 - 2020, USD Million
  • TABLE 63 Rest of North America Transcriptomics Market by Application, 2021 - 2027, USD Million
  • TABLE 64 Rest of North America Transcriptomics Market by Component, 2017 - 2020, USD Million
  • TABLE 65 Rest of North America Transcriptomics Market by Component, 2021 - 2027, USD Million
  • TABLE 66 Key Information - Fluidigm Corporation
  • TABLE 67 key Information - Promega Corporation
  • TABLE 68 Key Information - General Electric (GE) Co.
  • TABLE 69 KEY INFORMATION - MERCK & CO., INC.
  • TABLE 70 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 71 key information - Illumina, Inc.
  • TABLE 72 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 73 key Information - Agilent Technologies, Inc.
  • TABLE 74 key information - F. Hoffmann-La Roche Ltd.
  • TABLE 75 Key Information - Qiagen N.V.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
  • FIG 4 Key Strategic Move: (Acquisitions and Mergers: 2019, Jan - 2021, Apr) Leading Players
  • FIG 5 Key Strategic Move: (Product Launches ad Product Expansions: 2018, Mar - 2021, Nov) Leading Players
  • FIG 6 Swot analysis: thermo fisher scientific, inc.
  • FIG 7 Recent strategies and developments: Bio-Rad Laboratories, Inc.
  • FIG 8 Recent strategies and developments: Qiagen N.V.